ARTICLE | Company News
Hybrigenics SA, Semaia BV deal
May 5, 2003 7:00 AM UTC
Proteomics company Hybrigenics acquired Semaia, which focuses on signal transduction in cancer, in a stock deal. Hybrigenics will use its functional proteomics technology to prioritize Semaia's target...